论文部分内容阅读
目的观察硝酸甘油、卡托普利治疗慢性肺心病心力衰竭的疗效及安全性。方法57例患者随机分为治疗组和对照组。对照组采用常规治疗;治疗组同时给予硝酸甘油、卡托普利治疗,观察患者症状及心功能好转情况。结果治疗组总有效率91.4%,对照组总有效率63.6%,两组疗效差异有显著性,治疗组明显高于对照组(P<0.05)。结论硝酸甘油、卡托普利有少数患者不能耐受,但密切观察患者的症状体征的情况下,在慢性肺心病心力衰竭治疗过程中应用硝酸甘油、卡托普利还是安全的,能够取得较好的疗效。
Objective To observe the efficacy and safety of nitroglycerin and captopril in the treatment of heart failure due to chronic cor pulmonale. Methods 57 patients were randomly divided into treatment group and control group. The control group received routine treatment; the treatment group was treated with nitroglycerin and captopril simultaneously to observe the symptoms and the improvement of cardiac function. Results The total effective rate was 91.4% in the treatment group and 63.6% in the control group. There was significant difference between the two groups in curative effect, which was significantly higher in the treatment group than in the control group (P <0.05). Conclusions A small number of patients with nitroglycerin and captopril can not tolerate. However, in patients with chronic cor pulmonale and heart failure, the application of nitroglycerin and captopril is safe when they are closely observed in patients with symptoms and signs. Good effect.